What You Should Know:
- Tandem Diabetes Care (TNDM) and Dexcom (DXCM) announced today that the Tandem Mobi insulin pump with Control-IQ technology is now compatible with both the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) systems.
- Overall, the Tandem Mobi and Dexcom G7 combination empowers people with diabetes with a discreet, convenient, and technologically advanced solution for managing their condition.
Tandem Mobi: Small Pump, Big Choice for Diabetes
Read More
Continuous Glucose Monitoring (CGM)
MD Revolution & Dexcom Integrate Remote Glucose Monitoring
What You Should Know:
- MD Revolution, known for its remote care management solutions, collaborates with Dexcom to integrate cutting-edge continuous glucose monitoring systems into its platform.
- Dexcom, a global leader in real-time continuous glucose monitoring, serves over 537 million individuals worldwide living with diabetes. Through wearable devices synced with smartphones, patients' glucose data becomes accessible to clinicians via MD Revolution's care management platform,
Read More
Biolinq Secures $58M to Advance Continuous Glucose Monitoring Patch
What You Should Know:
- Biolinq, a provider of precision wearable biosensors for metabolic health secures $58M led by Alpha Wave Ventures. The round will include participation from Niterra’s corporate venture capital fund jointly operated with Pegasus Tech Ventures and existing investors RiverVest Venture Partners, AXA IM Alts, Global Health Investment Corporation, Aphelion Capital, Senvest Management, Features Capital and Taisho Pharmaceutical. J.P. Morgan served as a placement agent to
Read More
Know Labs Unveils KnowU: Wearable Non-Invasive CGM Poised to Revolutionize Glucose Monitoring
What You Should Know:
- Know Labs (NYSE American: KNW), a leading innovator in non-invasive medical diagnostic technology, today announced the unveiling of its KnowU™, a wearable, non-invasive continuous glucose monitor (CGM).
- With over 270 patents issued, pending, and in process, Know Labs has established a solid foundation for its technology, creating a competitive advantage in the non-invasive CGM landscape.
Wearable, Non-invasive Continuous Glucose Monitor
Just eight months
Read More
Rimidi and ARKRAY Partner to Bring Glucose Data to the EHR
What You Should Know:
- In an effort to make blood glucose data more actionable for providers and patients alike, Rimidi, a leading clinical management platform announced its integration with the ARKRAY GLUCOCARD® Shine Connex Blood Glucose Monitoring System to Rimidi’s Platform.
- The integration enables providers to manage blood-glucose control more proactively within existing workflows, thus boosting patient adherence.
Blood Glucose Data Directly Embedded in EHR
Diabetes is the
Read More
Early Use of Diabetes Technology Drives Better Patient Outcomes in Kids
A recent study from Stanford found that pediatric patients with rapid access to continuous glucose monitoring soon after a type 1 diabetes diagnosis had healthier blood sugar values than an earlier group of patients who weren’t given the monitors near the time of diagnosis.
The research provides an example of how the healthcare industry is evolving to use technology: It provides more frequent touchpoints with caregivers, makes quality care available to a larger number of patients, and
Read More
Smart Meter Launches iGlucose in 45+ Long-Term Care Facilities Nationwide
What You Should Know:
- Smart Meter, the leader in cellular-connected remote patient monitoring (RPM) devices, today announced the launch of its iGlucose cellular-connected blood glucose system in more than 45 long-term care (LTC) facilities across the U.S.
- iGlucose is an easy-to-use, single patient use blood glucose meter (BGM) that improves clinical efficiencies, infection control efforts and patient outcomes with real-time data immediately sent to healthcare provider portals and
Read More
Teladoc Health, Dexcom Offers CGM-Powered Insights to People with Type 2 Diabetes
What You Should Know:
- Teladoc Health and Dexcom announced an expanded
partnership on a new offering measures the impact of continuous glucose
monitoring and real-time health recommendations for people with Type 2 diabetes
at no cost.
Teladoc Health, Inc., the first and only comprehensive virtual care system, and DexCom, Inc., the leader in real-time continuous glucose monitoring (CGM), today announced that joint Livongo for Diabetes and Dexcom members will now
Read More
4 Predictions for Diabetes Management and Technology in 2021
The COVID-19 pandemic continues to put an unprecedented amount of strain on the entire healthcare sector, and the industry has responded by accelerating the ways innovation is developed and adopted. Health leaders have faced a generational challenge and the result has been the rapid deployment of technology to address dire patient needs. Health systems, physicians, and frontline staff pulled together in remarkable fashion to implement these emerging technologies that enhance the ways patients
Read More
Is Glucometrics The Missing Data in the Fight Against COVID-19?
Glucometrics – the system-wide analysis of inpatient glucose data – should be of fundamental interest for hospital administrators striving to improve the outcomes of their patients.
Why is this data so important? Proper glycemic control has been linked to improved outcomes and decreased length of stay time and time again across a myriad of conditions – whether it’s someone recuperating from a heart attack, battling pneumonia, or recovering from surgery.
The U.S. health system lacks
Read More
